For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Oxaliplatin + Docetaxel | Oxaliplatin + Docetaxel as first line therapy of Stage IV or IIIB unresectable non-small cell lung cancer | None | None | 9 | 15 | 15 | 15 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Catheter infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| clostridium difficile colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| hemoptysis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pain | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| chest pain | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| DVT | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| concussion | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| pericardial effusion | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| anorexia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| dysguesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| thrombocytopenia | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |